Centene Corporation (CNC) Income Statement Analysis

See more : Capitec Bank Holdings Limited (CPI.JO) Income Statement Analysis – Financial Results

Complete financial analysis of Centene Corporation (CNC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Centene Corporation, a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.

You may be interested

Shanghai QiFan Cable Co., Ltd (605222.SS) Income Statement Analysis – Financial Results
Aditya Birla Sun Life AMC Limited (ABSLAMC.NS) Income Statement Analysis – Financial Results
Minds + Machines Group Limited (MMX.L) Income Statement Analysis – Financial Results
Tronox Pigmentos do Brasil S.A. (CRPG6.SA) Income Statement Analysis – Financial Results
Awakn Life Sciences Corp. (AWKNF) Income Statement Analysis – Financial Results

Centene Corporation (CNC)

Industry: Medical - Healthcare Plans

Sector: Healthcare

Website: https://www.centene.com

About Centene Corporation

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Revenue	154.00B	144.55B	125.98B	111.12B	74.64B	60.12B	48.38B	40.61B	22.76B	16.56B	10.86B	8.67B	5.34B	4.45B	4.10B	3.36B	2.92B	2.28B	1.51B	1.00B	769.73M	461.49M	326.57M	221.35M	201.43M
Cost of Revenue	122.46B	127.89B	111.78B	95.90B	65.80B	51.70B	42.58B	35.06B	20.01B	14.66B	9.65B	7.96B	4.40B	3.74B	3.45B	2.70B	2.39B	1.88B	1.23B	808.54M	8.32M	379.47M	270.15M	0.00	0.00
Gross Profit	31.54B	16.66B	14.20B	15.22B	8.84B	8.42B	5.80B	5.54B	2.75B	1.90B	1.21B	705.52M	937.72M	704.89M	652.66M	667.26M	533.35M	398.47M	273.10M	192.40M	761.41M	82.02M	56.42M	221.35M	201.43M
Gross Profit Ratio	20.48%	11.52%	11.27%	13.69%	11.85%	14.01%	11.99%	13.65%	12.07%	11.50%	11.13%	8.14%	17.56%	15.85%	15.91%	19.83%	18.27%	17.48%	18.14%	19.22%	98.92%	17.77%	17.28%	100.00%	100.00%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	0.00	0.00	10.17B	11.34B	6.53B	6.75B	4.45B	4.14B	2.04B	1.44B	931.14M	704.60M	477.77M	547.82M	514.53M	444.73M	399.69M	346.28M	193.91M	127.86M	88.29M	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	109.24M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	12.56B	11.59B	10.17B	11.34B	6.53B	6.75B	4.45B	4.14B	2.04B	1.44B	931.14M	704.60M	587.00M	547.82M	514.53M	444.73M	399.69M	346.28M	193.91M	127.86M	88.29M	50.41M	37.95M	32.34M	29.76M
Other Expenses	16.05B	1.43B	770.00M	719.00M	258.00M	211.00M	156.00M	147.00M	1.37B	824.00M	333.21M	456.39M	160.39M	165.12M	225.89M	90.97M	79.57M	81.10M	0.00	0.00	626.19M	379.47M	270.15M	182.50M	178.29M
Operating Expenses	28.61B	13.02B	10.94B	12.06B	6.79B	6.96B	4.60B	4.28B	2.04B	1.44B	931.14M	704.60M	747.40M	547.82M	514.53M	535.70M	479.26M	427.38M	193.91M	127.86M	714.48M	429.88M	308.10M	214.83M	208.04M
Cost & Expenses	151.07B	140.91B	122.72B	107.96B	72.59B	58.66B	47.18B	39.35B	22.06B	16.10B	10.59B	8.67B	5.15B	4.29B	3.96B	3.23B	2.87B	2.31B	1.43B	936.40M	722.80M	809.35M	578.25M	214.83M	208.04M
Interest Income	0.00	665.00M	665.00M	376.00M	443.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	725.00M	665.00M	665.00M	728.00M	412.00M	343.00M	255.00M	217.00M	43.00M	35.00M	26.96M	20.46M	20.32M	17.99M	16.32M	16.67M	15.63M	10.64M	3.99M	680.00K	194.00K	45.00K	0.00	0.00	0.00
Depreciation & Amortization	1.29B	1.43B	1.48B	1.26B	643.00M	495.00M	361.00M	278.00M	111.00M	89.00M	67.42M	65.87M	58.33M	52.00M	44.00M	35.41M	27.81M	20.60M	13.07M	10.01M	6.45M	2.57M	1.85M	1.03M	0.00
EBITDA	5.62B	4.06B	3.95B	4.76B	2.84B	2.21B	1.75B	1.65B	851.00M	581.00M	354.60M	66.78M	248.65M	224.27M	182.14M	166.98M	81.90M	9.58M	102.92M	74.55M	48.22M	43.75M	20.32M	7.55M	-6.61M
EBITDA Ratio	3.65%	3.59%	3.76%	3.97%	3.61%	3.25%	3.22%	3.79%	3.59%	3.34%	3.17%	0.77%	4.66%	4.70%	4.44%	4.96%	2.81%	-0.36%	6.13%	7.45%	6.26%	-76.90%	-77.70%	2.84%	-3.28%
Operating Income	2.93B	3.64B	3.26B	3.08B	1.78B	1.46B	1.20B	1.26B	705.00M	464.00M	277.42M	-27.12M	190.32M	157.07M	138.14M	131.56M	54.09M	-28.91M	79.19M	64.54M	46.93M	31.61M	18.47M	6.52M	-6.61M
Operating Income Ratio	1.90%	2.52%	2.59%	2.77%	2.39%	2.43%	2.48%	3.10%	3.10%	2.80%	2.55%	-0.31%	3.56%	3.53%	3.37%	3.91%	1.85%	-1.27%	5.26%	6.45%	6.10%	6.85%	5.66%	2.95%	-3.28%
Total Other Income/Expenses	668.00M	644.00M	29.00M	-309.00M	1.00M	-90.00M	-65.00M	-103.00M	-8.00M	-7.00M	-8.50M	-181.62M	-28.92M	-2.79M	-627.00K	5.06M	9.54M	7.26M	6.67M	5.75M	4.97M	9.53M	3.55M	665.00K	1.13M
Income Before Tax	3.60B	1.96B	1.81B	2.77B	1.78B	1.37B	1.13B	1.16B	697.00M	457.00M	268.92M	-11.62M	174.89M	154.28M	137.51M	136.62M	63.64M	-21.65M	85.86M	70.29M	51.89M	41.14M	22.03M	7.19M	-5.48M
Income Before Tax Ratio	2.34%	1.36%	1.44%	2.50%	2.39%	2.28%	2.34%	2.85%	3.06%	2.76%	2.48%	-0.13%	3.27%	3.47%	3.35%	4.06%	2.18%	-0.95%	5.70%	7.02%	6.74%	8.91%	6.74%	3.25%	-2.72%
Income Tax Expense	899.00M	760.00M	477.00M	979.00M	473.00M	474.00M	326.00M	599.00M	339.00M	196.00M	107.08M	-329.00K	66.52M	59.90M	48.84M	52.44M	22.37M	21.98M	30.22M	25.98M	19.50M	15.63M	9.13M	-543.00K	3.93M
Net Income	2.70B	1.20B	1.35B	1.81B	1.32B	900.00M	828.00M	562.00M	355.00M	271.00M	165.10M	1.86M	111.22M	94.84M	83.67M	83.50M	73.40M	-43.63M	55.63M	44.31M	33.27M	25.62M	12.90M	7.73M	-9.41M
Net Income Ratio	1.75%	0.83%	1.07%	1.63%	1.77%	1.50%	1.71%	1.38%	1.56%	1.64%	1.52%	0.02%	2.08%	2.13%	2.04%	2.48%	2.51%	-1.91%	3.69%	4.43%	4.32%	5.55%	3.95%	3.49%	-4.67%
EPS	4.97	2.09	2.31	3.17	3.19	2.31	2.40	1.76	1.49	1.17	0.76	0.01	0.56	0.49	0.49	0.48	0.42	-0.25	0.33	0.27	0.23	0.21	0.75	0.67	-0.87
EPS Diluted	4.95	2.07	2.28	3.12	3.14	2.26	2.35	1.72	1.44	1.13	0.74	0.01	0.53	0.47	0.47	0.47	0.41	-0.25	0.31	0.26	0.22	0.18	0.13	0.09	-0.87
Weighted Avg Shares Out	543.32M	575.19M	582.83M	570.72M	413.49M	390.25M	345.00M	319.14M	238.20M	232.69M	216.51M	206.04M	200.80M	195.02M	172.14M	173.10M	174.16M	172.64M	169.25M	163.28M	142.82M	125.73M	16.62M	10.82M	10.81M
Weighted Avg Shares Out (Dil)	545.70M	582.04M	590.52M	579.14M	420.41M	398.51M	353.09M	327.95M	246.13M	240.72M	224.99M	214.86M	209.90M	201.79M	177.27M	177.60M	179.29M	172.64M	180.11M	174.47M	153.69M	139.73M	96.23M	81.84M	10.81M

CENTENE CORPORATION TO HOST VIRTUAL INVESTOR DAY ON DECEMBER 12, 2024

December 5, 2024prnewswire.com

ST. LOUIS , Dec. 5, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced that, in the wake of the tragic loss of UnitedHealthcare's CEO Brian Thompson, Centene's Investor Day will...

CENTENE FOUNDATION PARTNERS WITH THE NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS TO STRENGTHEN COMMUNITY HEALTH DELIVERY

December 4, 2024prnewswire.com

Three-year partnership to increase value-based payment model adoption and improve maternal and child health outcomes in community health centers, impacting up to 1 in 5 Medicaid members ST. LOUIS , Dec. 4, 2024 /PRNewswire/ -- The Centene Foundation ("The Foundation"), the...

CENTENE CORPORATION TO HOST INVESTOR DAY ON DECEMBER 12, 2024

December 3, 2024prnewswire.com

ST. LOUIS , Dec. 3, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced that it will host an investor day on Thursday, December 12, 2024, starting at 8:30 a.m. Eastern...

Centene Corporation - Digital Transformation Strategy Report 2024: Details of Estimated ICT budgets and Major ICT Contracts

November 25, 2024globenewswire.com

Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Centene Corporation - 2024" company profile has been added to ResearchAndMarkets.com's offering.

Meridian Health Plan of Illinois and Liberty Bank and Trust Partner to Create Small Business Loan Program to Support and Empower Diverse and Small Businesses in Illinois

November 21, 2024prnewswire.com

$500,000 grant from Meridian will support $2.5 million in lending power to fuel growth and community development CHICAGO , Nov. 21, 2024 /PRNewswire/ -- Meridian Health Plan of Illinois, Inc. (Meridian), a provider of government-sponsored managed care services to families, children,...

3 Stocks Seeing Insider Buys: CNC, PFE, BMY

November 12, 2024zacks.com

Investors can see insider buys as an overall net positive concerning the longer-term outlook for a stock.

Sunshine Health Announces the Appointment of Charlene Zein as President and CEO

November 7, 2024prnewswire.com

PEMBROKE PINES, Fla. , Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE: CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024.